Ramky Infrastructure: Sells 51% Stake In Visakha Pharmacity For Rs 165.24 Crore
Ramky Infrastructure Limited has successfully executed a Share Purchase Agreement for the divestment of its 51% stake in subsidiary Visakha Pharmacity Limited to Brij Gopal Construction Company Private Limited for ₹165.24 crores. The transaction involves transfer of 91,80,000 equity shares and was completed on March 30, 2026, with full consideration received and share transfers to be completed within 10 days as per the agreement terms.

*this image is generated using AI for illustrative purposes only.
Ramky Infrastructure Limited has successfully executed a Share Purchase Agreement for the sale of its subsidiary Visakha Pharmacity Limited shares to Brij Gopal Construction Company Private Limited. The transaction, valued at ₹165.24 crores, was completed on March 30, 2026, following the board approval granted on March 28, 2026.
Transaction Execution and Financial Details
The company has received the full consideration amount of ₹165.24 crores for the transfer of 91,80,000 equity shares representing 51% stake in Visakha Pharmacity Limited. The share transfers will be completed within the timeframes specified in the Share Purchase Agreement.
| Transaction Parameter: | Details |
|---|---|
| Agreement Date: | March 30, 2026 |
| Consideration Amount: | ₹165.24 crores |
| Shares Sold: | 91,80,000 equity shares (51% stake) |
| Buyer: | Brij Gopal Construction Company Private Limited |
| Completion Timeline: | Within 10 days from SPA execution |
Visakha Pharmacity Financial Performance Overview
Visakha Pharmacity Limited's contribution to Ramky Infrastructure's consolidated financials demonstrates the subsidiary's operational significance. The financial metrics highlight the subsidiary's performance during 2024-25.
| Financial Metric: | Consolidated 2024-25 (₹ million) | Standalone 2024-25 (₹ million) |
|---|---|---|
| Turnover: | 4,093.29 | 4,012.59 |
| Profit Before Tax: | 400.37 | 420.86 |
| Profit After Tax: | 296.56 | 317.32 |
| Net Worth: | 3,023.26 | 3,055.76 |
Board Authorization and Regulatory Compliance
The board meeting held on March 28, 2026, from 05:45 PM to 06:15 PM, had previously authorized the Managing Director and Chief Financial Officer to finalize the Share Purchase Agreement terms. This transaction aligns with the approval accorded by company members through a postal ballot process initiated on December 27, 2023, with results declared on January 28, 2024.
Transaction Structure and Buyer Details
The sale involves transferring Ramky Infrastructure's entire 51% shareholding in Visakha Pharmacity Limited to Brij Gopal Construction Company Private Limited, which does not belong to the promoter group. The transaction is classified as a non-related party transaction and will be completed within 10 days from the SPA execution date.
Regulatory Disclosure Framework
Ramky Infrastructure has provided comprehensive disclosures under SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 following the Share Purchase Agreement execution. The announcement was communicated to both NSE and BSE, signed by Company Secretary N. Kesava Datta, ensuring adherence to corporate governance standards and regulatory protocols.
Historical Stock Returns for Ramky Infrastructure
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.54% | -2.79% | -1.63% | -22.83% | -2.06% | +488.86% |
How will Ramky Infrastructure deploy the ₹165.24 crores proceeds from this divestiture across its core infrastructure projects?
What strategic rationale drove Brij Gopal Construction Company to acquire a majority stake in a pharmaceutical city development project?
Will this divestiture signal Ramky Infrastructure's broader exit from non-core assets to focus on traditional infrastructure segments?


































